Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06392282
MV-140 Efficacy in Recurrent Urinary Tract Infections in a Cohort of Portuguese Adult Patients
Sponsor: Unidade Local de Saúde Santa Maria
View on ClinicalTrials.gov
Summary
We will access the efficacy of MV-140 immunotherapy in the prevention of recurrent urinary tract infections in a cohort of Portuguese patients.
Official title: MV-140 Efficacy in Recurrent Urinary Tract Infections
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
104
Start Date
2023-06-01
Completion Date
2024-05-01
Last Updated
2024-04-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
MV-140
MV-140 use - sublingual spray approved for recurrent UTI prevention
Locations (1)
Hospital de Santa Maria
Lisbon, Lisbon District, Portugal